EGFR and neoplasm: Tumours that have epidermal growth factor receptor (EGFR) amplification, telomerase reverse transcriptase (TERT) promoter mutation, or concurrent chromosome 7 gain/chromosome 10 loss exhibit a clinical course similar to that of GBM (8, 9).